Interest / Registration on waiting list
Starting in fall 2026
Subject to validation by HES-SO authorities.
Designed to integrate a good balance of theory and hands-on practice, the CARAQA program provides a high-level preparation to match the competences in Regulatory, Clinical, and Quality required by the MedTech Industry, including the requirements for the Medical Device Regulation (2017/745), In vitro diagnostic device regulation (2017/746) and FDA. This program is proposed in partnership with Veranex (previously Medidee Services).
The CARAQA training is structured around three areas: Clinical Affairs, Regulatory Affairs and Quality Assurance - CA/RA/QA. Understanding and connecting these is essential for professionals in the field. As this landscape is still very dynamic and the requirements set by the European Commission are constantly evolving, the content of the program will be continuously adapted to reflect the current needs and challenges of the medical device and in vitro diagnostics industry.
The CAS CARAQA begins with a comprehensive introduction to the world of medical devices and in-vitro diagnostics, providing participants with a solid understanding of the MedTech environment, product lifecycles and effective interaction with the stakeholders involved.
Regulatory Affairs covers the management, implementation and application of regulations, standards and guidance documents. It covers the essential practices of integrating regulatory requirements into product design and lifecycle, ensuring that the content and structure of technical documentation meet regulatory requirements, and the implementation and application of risk management. While the main focus will be on the European market, other regulations such as for the US, Canada, Asia will be introduced.
Quality Management covers the structure of a quality management system, managing its documentation, and critical quality processes such as audits, improvements and changes. Special attention is given to ISO 13485 Quality Management for Medical Devices, US CFR21 820 and the MDSAP programme.
Clinical Affairs includes the structure and management of clinical or performance evaluations, the organisation of clinical investigations, aspects of clinical trials and their design strategies, and the conduct of literature reviews. Post market activities such as Post Market Surveillance (PMS) or Post Market Clinical Follow-up (PMCF) are covered in this section.
With hot topics affecting the world of medical devices and in vitro diagnostics, such as artificial intelligence or the General Data Protection Regulation (GDPR), the programme is constantly being revised and adapted. The course is designed to equip you to deal comprehensively with all facets of medical devices and in vitro diagnostics.
The programme is tailored to equip participants with the essential skills required by the medical device and in vitro diagnostics industries. With the evolving dynamics of CA/RA/QA roles, our aim is to cultivate a diverse set of technical and interpersonal skills. These will prepare participants to progress to decision-making positions within their organisations and play a pivotal role in maintaining the company's competitive edge and long-term viability.
The CAS CARAQA develops the following skills:
The programme is aimed at people in medical device and in vitro medical device companies and suppliers who are directly or indirectly facing challenges in a CA/RA/QA environment. Individuals wishing to develop their skills in this direction are also very welcome.
The programme will start in automn 2026. It takes place at Campus Biotech, in Geneva. Lessons are every Friday, with a break during Christmas and New Year, and lasts until spring 2027.
The programme ends with a final written exam and the writing and presentation of an individual thesis. The subject of the thesis is a complete CA/RA/QA study of a medical device or IVD device according to guidelines set out in the programme. The device can be chosen individually by each participant and can be related to his/her professional activities. The thesis is written in English.
Study plan (pdf to join)
Registration deadline: Coming soon
Information meeting: Not planned yet
Start of the course: Automn 2026
Organization: 28 days - 7 months + Thesis 2 months
Studies fees:
Place: Campus Biotech, Geneva
Credits: 15 ECTS-Credits
Tertiary educational qualification (at least Bachelor degree level) and relevant professional experience or Federal Diploma of Higher Education (from a Swiss “Höhere Fachschule” or “eidg. HFP” or “eidg. BP”), and at least 3 years of relevant professional experience in a subject relevant to or related to the continuing training programme.
Interested persons without tertiary educational qualification can be admitted, if they have a minimum of 5 years professional experience in a subject relevant to or related to the continuing education programme and if they have successful completed various continuing training courses (in-company or CAS/MAS/DAS) or discontinuation of tertiary education with advanced participation or partial achievement (> 50%)
As the instruction and educational materials are in English, proficiency in English (minimum level C1) is a prerequisite.
Graduates receive a CAS "Certificate of Advanced Studies" worth 15 ECTS, which is recognized by the HES-SO and at European level in accordance with the Bologna Agreements.
Formation continue HEPIA
+41 22 558 56 70
fc.hepia@hesge.ch
Programm manager
Professeure HES assistante
HEPIA